A Multicenter, Randomized Trial Comparing Heparin/Warfarin and Acetylsalicylic Acid as Primary Thromboprophylaxis for 2 Years After the Fontan Procedure in Children-Reference-Cited by-同舟云学术

A Multicenter, Randomized Trial Comparing Heparin/Warfarin and Acetylsalicylic Acid as Primary Thromboprophylaxis for 2 Years After the Fontan Procedure in Children

Published:2011-08 Issue:6 Volume:58 Page:645-651
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Monagle Paul,Cochrane Andrew,Roberts Robin,Manlhiot Cedric,Weintraub Robert,Szechtman Barbara,Hughes Marina,Andrew Maureen,McCrindle Brian W.

Funder

Heart and Stroke Foundation of Ontario

National Heart Foundation of Australia

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference19 articles.

1. Thromboembolic complications after fontan procedures--the role of prophylactic anticoagulation;Monagle;J Thorac Cardiovasc Surg,1998

2. Improved early morbidity and mortality after Fontan operation: the Mayo Clinic experience, 1987 to 1992;Cetta;J Am Coll Cardiol,1996

3. Five- to fifteen-year follow-up after Fontan operation;Driscoll;Circulation,1992

4. Modified Fontan operation for univentricular heart and complicated congenital lesions;Gale;J Thorac Cardiovasc Surg,1979

5. Long-term survival, modes of death, and predictors of mortality in patients with Fontan surgery;Khairy;Circulation,2008

Cited by 211 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Comparative effectiveness among thromboprophylaxis strategies after the Fontan operation: A systematic review and network meta-analysis;Thrombosis Research;2024-09

2. Efficacy and safety of antithrombotic therapy for preventing and treating pediatric thromboembolic disease: a systematic review;Scientific Reports;2024-06-11

3. Long-term outcomes of extracardiac Gore-Tex conduits in Fontan patients;International Journal of Cardiology Congenital Heart Disease;2024-06

4. Dabigatran for Treatment and Secondary Prevention of Venous Thromboembolism in Pediatric Congenital Heart Disease;Journal of the American Heart Association;2024-02-20

5. Fontan Patients;Pediatric Cardiology;2024